Coming Soon

A5360: Minimal Versus Standard Monitoring for the Delivery of All Oral Ribavirin-Free Pan Genotypic Directly Acting Antivirals to Chronically Infected Treatment Naïve HCV Populations Globally: MINMON Study

Amgen Repatha: A Double Blind, Randomized, Placebo Controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy on LDL-C of Evolocumab (AMG 145) in Subjects with HIV and with Hyperlipedemia and/or Mixed Dyslipidemia


XTRA Study: A Phase I Study to Evaluate the Effects of Vorinostat and HIV-1 Antigen Expanded Specific T-Cell Therapy (HXTC) on Persistent HIV-1 Infection in HIV-Infected Individuals Started on Antiretroviral Therapy